The screening funnel from first phone call to enrollment, why most applicants get filtered out, and what you can honestly do about it.
To qualify for a clinical trial you must match the study's inclusion criteria (age, health status, sometimes a specific condition) and trip none of its exclusion criteria (medications, recent illnesses, other trial participation). The process runs pre-screen phone call, then an in-person screening visit with medical history and labs, then informed consent, then enrollment — typically 1 to 3 weeks end to end.
Most people who apply for any given study do not get in, and that is by design: narrow criteria are what make trial results scientifically valid and keep participants safe. The good news is that being screened out of one study says nothing about the next. Here is how the funnel works and how to move through it efficiently and honestly.
Every trial publishes its criteria on ClinicalTrials.gov, the NIH registry. Inclusion criteria define who the study needs: an age range, a BMI band, healthy status for Phase 1, or a confirmed diagnosis for later-phase studies. Exclusion criteria list the dealbreakers: certain medications, chronic conditions, recent surgeries, pregnancy or breastfeeding, smoking, out-of-range lab values, and participation in another study within the washout window — typically 30 days minimum.
Read the listing before calling. Two minutes of self-checking against the published criteria saves you a wasted screening trip and flags questions worth raising, like whether an old diagnosis or an occasional medication actually disqualifies you. Borderline cases are decided by the study clinicians, not the listing — so ask rather than assume.
Expect one to three weeks from first call to enrollment, and be reachable — coordinators fill fast-moving studies in call-list order, and an unanswered phone quietly costs more slots than any failed lab value. If your timeline shifts or you enroll elsewhere, tell the coordinator; sites remember volunteers who communicate.
Common reasons: a lab value slightly outside protocol range, BMI just over the band, blood pressure on the day, an over-the-counter medication you forgot to mention, a positive nicotine test, or simply the study filling up before your slot. None of these are health verdicts. Protocol ranges are often narrower than clinical normal, because researchers need uniform participants, not because your numbers are worrying.
Screen-fails are so routine that experienced volunteers budget for them. If something in your labs does look medically noteworthy, the site will tell you and suggest you see your physician — one of the incidental benefits of screening. Then you move on to the next study; sites in dense markets like Miami or Phoenix open new protocols every month.
Join the free email alert — we watch the NIH registry weekly so you don't have to.
Get trial alertsIt can be tempting to omit a medication, shave your weight, or forget a recent study. Do not. Exclusion criteria exist because certain combinations are dangerous: an undisclosed drug can interact with the study compound, an undisclosed condition can turn a mild side effect into an emergency, and a skipped washout can put two experimental drugs in your body at once. Screening is the safety system, and it only works on true inputs.
Deception also corrupts the data that future patients will rely on, and sites do catch it — labs, drug screens, and cross-site registries exist precisely for this. Get screened out honestly and you remain a trusted name in the database; get caught lying and you are done at that site. For the broader protections around you, read are clinical trials safe.
Get an email when a new clinical trial starts recruiting within 30 miles of your ZIP code. No spam — only real studies from the NIH registry.